NCT00825799

Serum Markers as a Bioassay for Unipolar Depression

Validation of Serum Markers as a Bioassay for Unipolar Depression

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 160 (actual)
• Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc. · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is that the assay can serve as a diagnostic tool that would be more objective than standard diagnostic questionnaires.

Conditions

• Major Depression

Timeline

• Start date: 2007-11-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2009-01-21
• Last updated: 2014-01-03

Locations

1 site across 1 country: United States